Xinan Wu

机构：Hefei First People's Hospital · ORCID：0000-0002-3211-9730

发表论文 191 篇 · 总被引 2315 次 · h-index 25

代表论文

• Knockdown of Malat1 alleviates high-glucose-induced angiogenesis through regulating miR-205-5p/VEGF-A axis (2021 · Experimental Eye Research · 被引 39)
• Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal Anti-Inflammatory Drugs for Musculoskeletal Pain (2022) (2023 · Journal of Clinical Medicine · 被引 27)
• Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel (2023 · Journal of Pharmaceutical Analysis · 被引 23)
• Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system (2023 · Frontiers in Pharmacology · 被引 20)
• Characterization of the renal tubular transport of creatinine by activity-based protein profiling and transport kinetics (2022 · European Journal of Pharmaceutical Sciences · 被引 14)
• Investigating Intestinal Transporter Involvement in Rivaroxaban Disposition through Examination of Changes in Absorption (2021 · Pharmaceutical Research · 被引 14)